Royal Bank Of Canada Neuro Bo Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$2.73 - $4.52 $3,177 - $5,261	-1,164 Reduced 87.52%	166 $1,000
Q2 2021 Aug 16, 2021	BUY	$2.74 - $4.63 $3,644 - $6,157	1,330 New	1,330 $4,000

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.